Trial Profile
Phase II Study of Myeloablative Preparative Regimen Comprising Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Patients Undergoing Unrelated Umbilical Cord Blood Transplantation for Hematologic Malignancies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Ciclosporin; Filgrastim; Mycophenolate mofetil
- Indications Graft-versus-host disease; Haematological malignancies
- Focus Therapeutic Use
- 06 Dec 2019 Status changed from active, no longer recruiting to completed.
- 18 Feb 2019 Status changed to active, no longer recruiting.
- 21 Sep 2018 Status changed from recruiting to completed.